Business

OptimizeRx Reports Second Quarter 2020 Revenue Up 25% to a Record $8.8 Million; First Half Revenue up 34% to Record $16.4 Million, with Accelerated Growth Expected in Second Half

ROCHESTER, Mich., Aug. 05, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science

articleOptimizerx CorporationAugust 5, 20203/company/optimizerx-corp/news/optimizerx-reports-second-quarter-2020-revenue-up-25percent-to-a-record-dollar88-million-first-half-revenue-up-34percent-to-record-dollar164-million-with-accelerated-growth-expected-in-second-half
OptimizeRx Reports Second Quarter 2020 Revenue Up 25% to a Record $8.8 Million; First Half Revenue up 34% to Record $16.4 Million, with Accelerated Growth Expected in Second Half

About this update from Optimizerx Corporation

[{"type":"text","content":"ROCHESTER, Mich., Aug. 05, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results for the second quarter and six months ended June 30, 2020. Quarterly and first half comparisons are to the same year-ago period.\n Financial Highlights Revenue increased 25% to a record $8.8 million in second quarter of 2020, first half of 2020 up 34% to a record $16.4 million.Gross profit increased 19% to $5.1 million in the second quarter of 2020.Cash and cash equivalents totaled $14.1 million at June 30, 2020.Closed additional enterprise deals, bringing total value of enterprise-level engagements to $21 million in annualized revenue.Accelerated growth expected in second half of 2020. Q2 2020 Operational Highlights Finalized a new partnership that expands the company’s digital communication platform by more than 300 health systems and 125,000 healthcare providers that use the market-leading Epic and Cerner electronic health records systems (EHRs).Launched TelaRep™ for on-demand virtual consults that support physicians treating patients with complex diseases in COVID-19 world.True™ Women’s Health launched a new mobile app powered by OptimizeRx’s RMDY digital health tools that enables the clinic to use telehealth to treat patients nationwide with personalized health and wellness programs during the COVID-19 pandemic.Recognized as one of The Americas' 500 Fastest-Growing Companies by The Financial Times.Chief commercial officer, Stephen Silvestro, was honored with the 2020 PM360 ELITE 100 Award for his organizational leadership and positive impact on the healthcare industry.Hosted new webinar series featuring industry thought leaders covering a range of topics around using digital health technology to improve patient care, engagement and outcomes. Q2 2020 Financial Summary Total revenue in the second quarter of 2020 increased 25% to a record $8.8 million versus $7.0 million in the same year-ago quarter. The quarterly increase was due to increased sales of messaging solutions. Gross margin decreased to 58.6% in the second quarter of 2020 from 61.6% in the year-ago quarter. The decrease was due to an unusually favorable product mix in the year-ago period that had a high percentage of launch assistance services and other nonrecurring ...

More updates from Optimizerx Corporation